Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4815831> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q4815831 subject Q8431759.
- Q4815831 subject Q8791920.
- Q4815831 subject Q8808791.
- Q4815831 abstract "Atiprimod (INN, codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. This drug is also being researched as a potential treatment for various autoimmune diseases. It was first developed by GlaxoSmithKline as a potential treatment for rheumatoid arthritis. The substance is also known as azaspirane, although this more properly refers to the class of chemicals to which atiprimod belongs.".
- Q4815831 atcPrefix "none".
- Q4815831 casNumber "123018-47-3".
- Q4815831 fdaUniiCode "MG7D3QD743".
- Q4815831 iupacName "3-(8,8-dipropyl-3-azaspiro[4.5]decan-3-yl)-N,N- diethylpropan-1-amine".
- Q4815831 pubchem "129869".
- Q4815831 thumbnail Atiprimod.svg?width=300.
- Q4815831 wikiPageExternalLink dictionary?CdrID=486451.
- Q4815831 wikiPageWikiLink Q12078.
- Q4815831 wikiPageWikiLink Q1216998.
- Q4815831 wikiPageWikiLink Q187255.
- Q4815831 wikiPageWikiLink Q212322.
- Q4815831 wikiPageWikiLink Q221681.
- Q4815831 wikiPageWikiLink Q268713.
- Q4815831 wikiPageWikiLink Q29725.
- Q4815831 wikiPageWikiLink Q467635.
- Q4815831 wikiPageWikiLink Q8084905.
- Q4815831 wikiPageWikiLink Q824258.
- Q4815831 wikiPageWikiLink Q8431759.
- Q4815831 wikiPageWikiLink Q8791920.
- Q4815831 wikiPageWikiLink Q8808791.
- Q4815831 wikiPageWikiLink Q885070.
- Q4815831 wikiPageWikiLink Q988343.
- Q4815831 atcPrefix "none".
- Q4815831 casNumber "123018".
- Q4815831 iupacName "3".
- Q4815831 pubchem "129869".
- Q4815831 unii "MG7D3QD743".
- Q4815831 type ChemicalSubstance.
- Q4815831 type Drug.
- Q4815831 type ChemicalObject.
- Q4815831 type Thing.
- Q4815831 type Q8386.
- Q4815831 comment "Atiprimod (INN, codenamed SK&F106615) is a substance being studied in the treatment of certain multiple myelomas and other advanced cancers. It may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. This drug is also being researched as a potential treatment for various autoimmune diseases. It was first developed by GlaxoSmithKline as a potential treatment for rheumatoid arthritis.".
- Q4815831 label "Atiprimod".
- Q4815831 depiction Atiprimod.svg.